Hexagon Nutrition Limited is set to launch its initial public offering (IPO) on Friday, June 05, 2026. The Anchor Investor Bidding Date has been fixed as Thursday, June 04, 2026, while the Bid/Offer Closing Date will be Tuesday, June 09, 2026.
The company has fixed the price band of the offer at ₹42 per equity share to ₹45 per equity share, each with a face value of ₹1. Investors can bid for a minimum of 333 equity shares and in multiples of 333 equity shares thereafter.
The IPO comprises an offer for sale (OFS) of up to 30,859,704 equity shares aggregating up to ₹1,388.69 million (₹138.87 crore calculated at the upper end of the price band) by existing shareholders including Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Aditya Kelkar (“Promoter Selling Shareholder”) and Nutan Subhash Kelkar (“Promoter Group Selling Shareholder”).
Hexagon Nutrition Limited operates as a focused nutrition company with a differentiated and research-oriented approach across the nutrition value chain. The company has operations spanning branded wellness nutrition products and clinical nutrition products (B2C), premix formulations (B2B2C), and Ready to Use Foods (RUFs) and Micronutrient Powder (MNPs) in the ESG segment.
According to the CARE Report, the company is recognised as one of the largest premix players in India, supplying customised vitamin and mineral premixes to leading Indian and multinational FMCG companies. It is also among the largest licensed suppliers of MNPs under UN programmes supporting global food fortification and public health initiatives.
Hexagon Nutrition has an international distribution network spread across 19 non-exclusive regional distributors covering Latin America, Southeast Asia, Africa, and the Middle East. The company also maintains three overseas offices in South Africa, Uzbekistan, and Hong Kong to support its international business operations. Over the past three financial years, the company’s products have been exported to over 75 countries.
The company stated that it has positioned itself as a holistic nutrition company with global nutritional expertise.
The Offer is being made in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957 read with Regulation 31 of the SEBI ICDR Regulations. The Offer is being made for at least 25% of the post-offer paid-up equity share capital of the company.
The IPO is being conducted through the Book Building Process in accordance with Regulation 6(1) of the SEBI ICDR Regulations. In terms of Regulation 32(1), not more than 50% of the offer shall be available for allocation on a proportionate basis to Qualified Institutional Buyers (QIBs). The company may allocate up to 60% of the QIB portion to Anchor Investors on a discretionary basis.
Of the Anchor Investor Portion, 40% shall be reserved as follows: 33.33% for domestic mutual funds and 6.67% for life insurance companies and pension funds, subject to valid bids being received at or above the Anchor Investor Offer Price.
Further, 5% of the Net QIB Portion shall be available for allocation on a proportionate basis only to mutual funds, while the remaining Net QIB Portion shall be available to all QIBs, including mutual funds, subject to valid bids being received at or above the Offer Price.
Additionally, not less than 15% of the offer shall be available for allocation to Non-Institutional Bidders, while not less than 35% of the offer shall be available for allocation to Retail Individual Bidders in accordance with the SEBI ICDR Regulations.
All bidders, except Anchor Investors, are mandatorily required to utilise the Application Supported by Blocked Amount (ASBA) process by providing details of their respective ASBA accounts and UPI ID in case of UPI bidders.
The equity shares of the company are proposed to be listed on BSE Limited and the National Stock Exchange of India Limited (NSE). For the purposes of the Offer, NSE will serve as the Designated Stock Exchange.
Cumulative Capital Private Limited and Catalyst Capital Partners Private Limited are acting as the Book Running Lead Managers (BRLMs) to the issue.
The Red Herring Prospectus (RHP) dated May 25, 2026 is available at:
https://www.cumulativecapital.group/Admin/UploadedFiles/RHP-Hexagon-Nutrition-Limited-May-25,-2026.pdf